Costs associated with intravenous chemotherapy administration in patients with small cell lung cancer: a retrospective claims database analysis.

Objectives: With new oral chemotherapy drugs emerging, it is useful to understand the costs associated with traditional intravenous (IV) therapy. This study aims to assess costs associated with IV chemotherapy in patients with small cell lung cancer (SCLC) from the perspective of large employer-payers.

Study Design: Descriptive retrospective claims database analysis.